Literature DB >> 25722217

Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.

Wei Li1, Amritha Kidiyoor, Yangyang Hu, Changcheng Guo, Min Liu, Xudong Yao, Yuanyuan Zhang, Bo Peng, Junhua Zheng.   

Abstract

Transforming growth factor-β1 (TGF-β1) plays a dual role in apoptosis and in proapoptotic responses in the support of survival in a variety of cells. The aim of this study was to determine the function of TGF-β1 in bladder cancer cells and the relationship with POK erythroid myeloid ontogenic factor (Pokemon). TGF-β1 and its receptors mediate several tumorigenic cascades that regulate cell proliferation, migration, and survival of bladder cancer cells. Bladder cancer cells T24 were treated with different levels of TGF-β1. Levels of Pokemon, E-cadherin, Snail, MMP2, MMP9, Twist, VEGF, and β-catenin messenger RNA (mRNA) and protein were examined by real-time quantitative fluorescent PCR and Western blot analysis, respectively. The effects of TGF-β1 on epithelial-mesenchymal transition of T24 cells were evaluated with wound-healing assay, proliferation of T24 was evaluated with reference to growth curves with MTT assay, and cell invasive ability was investigated by Transwell assay. Data show that Pokemon was inhibited by TGF-β1 treatment; the gene and protein of E-cadherin and β-catenin expression level showed decreased markedly after TGF-β1 treatment (P < 0.05). While the bladder cancer cell after TGF-β1 treatment showed a significantly reduced wound-closing efficiency at 6, 12, and 24 h, mechanistic analyses demonstrated that different levels of TGF-β1 promotes tumor cell growth, migration, and invasion in bladder cancer cells (P < 0.01, P < 0.05, respectively). In summary, our findings suggest that TGF-β1 may inhibit the expression of Pokemon, β-catenin, and E-cadherin. The high expression of TGF-β1 leads to an increase in the phenotype and apical-base polarity of epithelial cells. These changes of cells may result in the recurrence and progression of bladder cancer at last. Related mechanism is worthy of further investigation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25722217     DOI: 10.1007/s13277-014-2625-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

Review 1.  Dual role for TGF-beta1 in apoptosis.

Authors:  Amelia Sánchez-Capelo
Journal:  Cytokine Growth Factor Rev       Date:  2005-01-25       Impact factor: 7.638

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer.

Authors:  Faruk Tas; Senem Karabulut; Murat Serilmez; Rumeysa Ciftci; Derya Duranyildiz
Journal:  Tumour Biol       Date:  2013-12-06

4.  ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.

Authors:  Thomas Waerner; Memetcan Alacakaptan; Ido Tamir; Rupert Oberauer; Annamaria Gal; Thomas Brabletz; Martin Schreiber; Martin Jechlinger; Hartmut Beug
Journal:  Cancer Cell       Date:  2006-09       Impact factor: 31.743

5.  Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.

Authors:  Fayth L Miles; Navpreet S Tung; Adam A Aguiar; Senem Kurtoglu; Robert A Sikes
Journal:  Prostate       Date:  2012-01-06       Impact factor: 4.104

6.  TGF-β and insulin signaling regulate reproductive aging via oocyte and germline quality maintenance.

Authors:  Shijing Luo; Gunnar A Kleemann; Jasmine M Ashraf; Wendy M Shaw; Coleen T Murphy
Journal:  Cell       Date:  2010-10-15       Impact factor: 41.582

7.  Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells.

Authors:  Fieke E M Froeling; Tariq A Mirza; Roger M Feakins; Angela Seedhar; George Elia; Ian R Hart; Hemant M Kocher
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

8.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Authors:  J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif
Journal:  Eur Urol       Date:  2013-12-12       Impact factor: 20.096

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer.

Authors:  Elizabeth Salvo; Saray Garasa; Javier Dotor; Xabier Morales; Rafael Peláez; Peter Altevogt; Ana Rouzaut
Journal:  Mol Cancer       Date:  2014-05-19       Impact factor: 27.401

View more
  9 in total

1.  The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder.

Authors:  Changcheng Guo; Dabo Xiong; Bin Yang; Haiming Zhang; Wenyu Gu; Min Liu; Xudong Yao; Junhua Zheng; Bo Peng
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

2.  Heterogeneous microenvironment analysis to explore the potential regulatory role of endothelial-mesenchymal transition in idiopathic pulmonary fibrosis.

Authors:  Yinning Xu; Xiaoping Hu; Yiwen Zhang; Zongfu Pan; Zhiyong Sun; Zhongjie Huang; Shuilian Zheng; Hansheng Pan; Xiaozhou Zou; Ping Huang
Journal:  Ann Transl Med       Date:  2022-04

3.  Evaluating the microRNA-target gene regulatory network in renal cell carcinomas, identification for potential biomarkers and critical pathways.

Authors:  Jun Li; Jian-Hua Huang; Qing-Hua Qu; Qier Xia; Deng-Shan Wang; Lei Jin; Chang Sheng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription.

Authors:  Jing Kong; Xiaoping Liu; Xiangqian Li; Jinsheng Wu; Ning Wu; Jun Chen; Fang Fang
Journal:  Hepatol Int       Date:  2016-01-21       Impact factor: 6.047

Review 5.  Role of ZBTB7A zinc finger in tumorigenesis and metastasis.

Authors:  Atul Kumar Singh; Shiv Verma; Prem Prakash Kushwaha; Kumari Sunita Prajapati; Mohd Shuaib; Shashank Kumar; Sanjay Gupta
Journal:  Mol Biol Rep       Date:  2021-05-20       Impact factor: 2.316

6.  Negative feedback loop between ZBTB7A and TGF-β in breast cancer.

Authors:  Yingying Shen; Renxian Cao; Wen Liu; Yuqing Zhou; Ying Wu; Jingjing Tan; Min Jin; Jing Zhong; Qinghai Zhang; Jianghua Liu; Xuyu Zu
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

7.  ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.

Authors:  Junqiang Liu; Zhiyuan Chou; Chun Li; Kai Huang; Xuejian Wang; Xiunan Li; Chuanchun Han; Abdullah Al-Danakh; Xiaodong Li; Xishuang Song
Journal:  Cancer Cell Int       Date:  2022-05-02       Impact factor: 6.429

8.  Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.

Authors:  Da-Jin Chen; Wei Chen; Hong Jiang; Hao Yang; Yu-Cheng Wang; Jiang-Hua Chen
Journal:  Drug Des Devel Ther       Date:  2016-09-08       Impact factor: 4.162

Review 9.  The multi-faceted functioning portrait of LRF/ZBTB7A.

Authors:  Caterina Constantinou; Magda Spella; Vasiliki Chondrou; George P Patrinos; Adamantia Papachatzopoulou; Argyro Sgourou
Journal:  Hum Genomics       Date:  2019-12-10       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.